Patent · US Expired

Pharmaceutical composition for treatment of BPH and preparation thereof

US7556828B2 · kind B2 · utility

1Cited by
3References
6Claims
0Family size

Inventors

Key dates

Filing dateApr 4, 2003
Grant dateJul 7, 2009
Priority date
Expiry dateApr 4, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P13/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition with higher curative effect on benign prostate hyperplasia and emiction disorders. It uses plants such as ginseng and ginkgo as well as cassia twig, cinnamon and liquorices as raw materials in both food and medicine. These raw materials are decocted or extracted separately in ethanol solution or water, then concentrated and dried to make the said pharmaceutical composition. Because this pharmaceutical composition is not toxic and has no side effect, it can be prepared as a medicament and health food to treat and improve benign prostate hyperplasia and emiction disorders caused by benign prostate hyperplasia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.